These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 3119938)

  • 21. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple acyl-coenzyme A dehydrogenase deficiency: diagnosis by acyl-carnitine analysis of a 12-year-old newborn screening card.
    Poplawski NK; Ranieri E; Harrison JR; Fletcher JM
    J Pediatr; 1999 Jun; 134(6):764-6. PubMed ID: 10356148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency.
    Olsen RK; Andresen BS; Christensen E; Bross P; Skovby F; Gregersen N
    Hum Mutat; 2003 Jul; 22(1):12-23. PubMed ID: 12815589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disorders of mitochondrial long-chain fatty acid oxidation.
    Pollitt RJ
    J Inherit Metab Dis; 1995; 18(4):473-90. PubMed ID: 7494405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons.
    Mienie LJ; Bergh JJ; Van Staden E; Steyn SJ; Pond SM; Castagnoli N; Van der Schyf CJ
    Life Sci; 1997; 61(3):265-72. PubMed ID: 9217286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
    Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
    Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency).
    Goodman SI; Frerman FE
    J Inherit Metab Dis; 1984; 7 Suppl 1():33-7. PubMed ID: 6434842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethylmalonic/adipic aciduria: effects of oral medium-chain triglycerides, carnitine, and glycine on urinary excretion of organic acids, acylcarnitines, and acylglycines.
    Rinaldo P; Welch RD; Previs SF; Schmidt-Sommerfeld E; Gargus JJ; O'Shea JJ; Zinn AB
    Pediatr Res; 1991 Sep; 30(3):216-21. PubMed ID: 1945558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.
    Chalmers RA; Stanley CA; English N; Wigglesworth JS
    J Pediatr; 1997 Aug; 131(2):220-5. PubMed ID: 9290607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C6-C10-dicarboxylic aciduria: biochemical considerations in relation to diagnosis of beta-oxidation defects.
    Gregersen N; Kølvraa S; Mortensen PB; Rasmussen K
    Scand J Clin Lab Invest Suppl; 1982; 161():15-27. PubMed ID: 6959231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the inborn errors of mitochondrial fatty acid beta-oxidation deficiency].
    Zhu JM; Yang Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):214-7. PubMed ID: 16617370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of mitochondrial fatty acid oxidation defects.
    Duran M; Bruinvis L; Ketting D; Dorland L
    Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal multiple acyl-CoA dehydrogenase deficiency: essentially absent fatty acid oxidation activity in proband but normal activity in parental cultured skin fibroblasts.
    Ip WC; Hammond JW; Wilcken B
    J Inherit Metab Dis; 1996; 19(3):379-80. PubMed ID: 8803790
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and biochemical aspects of glutaric acidemia type II.
    Goodman SI; Loehr JP; Frerman FE
    Prog Clin Biol Res; 1990; 321():465-76. PubMed ID: 2326307
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.
    Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL
    Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.
    Kler RS; Jackson S; Bartlett K; Bindoff LA; Eaton S; Pourfarzam M; Frerman FE; Goodman SI; Watmough NJ; Turnbull DM
    J Biol Chem; 1991 Dec; 266(34):22932-8. PubMed ID: 1744086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.